Data monitoring in complex clinical trials: Which treatment is ''better''? (Q1338366): Difference between revisions

From MaRDI portal
Importer (talk | contribs)
Created a new Item
 
ReferenceBot (talk | contribs)
Changed an Item
 
(5 intermediate revisions by 4 users not shown)
Property / author
 
Property / author: Janet Turk Wittes / rank
Normal rank
 
Property / author
 
Property / author: Janet Turk Wittes / rank
 
Normal rank
Property / MaRDI profile type
 
Property / MaRDI profile type: MaRDI publication profile / rank
 
Normal rank
Property / full work available at URL
 
Property / full work available at URL: https://doi.org/10.1016/0378-3758(94)90199-6 / rank
 
Normal rank
Property / OpenAlex ID
 
Property / OpenAlex ID: W2003324233 / rank
 
Normal rank
Property / cites work
 
Property / cites work: Predictive Probability Early Termination Plans For Phase II Clinical Trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Sample Sizes Based on the Log-Rank Statistic in Complex Clinical Trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Discrete Sequential Boundaries for Clinical Trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Stochastically curtailed tests in long–term clinical trials / rank
 
Normal rank
links / mardi / namelinks / mardi / name
 

Latest revision as of 10:37, 23 May 2024

scientific article
Language Label Description Also known as
English
Data monitoring in complex clinical trials: Which treatment is ''better''?
scientific article

    Statements